On April 2, the Trump administration announced a new round of tariffs, this time affecting the branded pharmaceutical industry. The threat of 100% tariffs on patented drug products and their active ingredients has the industry seeking to understand the explanations and its several exemptions. Yesterday, the White House issued a new set of tariffs on … Continue reading 100% Tariffs Slapped on Pharmaceutical Companies, With Many Exceptions: Circumventing the Supreme Court?